RETRACTED: Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways
Authors:
- Shu-Xiang CuiSCShu-Xiang Cui
- Yan WangYWYan Wang
- Han-Ni KeHKHan-Ni Ke
- Rui-Qi WangRWRui-Qi Wang
- Hong-Xiang LouHLHong-Xiang Lou
- Zu-Hua GaoZGZu-Hua Gao
- Xian-Jun QuXQXian-Jun Qu
- 1 October 2013
- journal article
- retracted article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1830 (10) , 4907-4916
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (91229113, 81173090, 81072665)
This publication has 43 references indexed in Scilit:
- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locationsCancer Letters, 2012
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trialsThe Lancet, 2012
- Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?The Scientific World Journal, 2012
- Aspirin for the prevention of colorectal cancerBest Practice & Research Clinical Gastroenterology, 2011
- IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signalsOncogene, 2011
- Fas/CD95 Deficiency in ApcMin/+ Mice Increases Intestinal Tumor BurdenPLOS ONE, 2010
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Acetyl-Keto-β-Boswellic Acid Induces Apoptosis through a Death Receptor 5–Mediated Pathway in Prostate Cancer CellsCancer Research, 2008
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003